Skip to main content
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: Cancer. 2013 Aug 6;119(21):10.1002/cncr.28295. doi: 10.1002/cncr.28295

Figure 2.

Figure 2

A. Kaplan-Meier analysis of two-year survival for patients with locoregional pancreatic adenocarcinoma, stratified by receipt of EUS. EUS group had improved survival (21.7% vs. 12.8%, p<0.0001).

B. Kaplan-Meier analysis of two year survival for patients with locoregional pancreatic adenocarcinoma and EUS, in patients who underwent surgery. EUS group had improved survival (42.5% vs. 33.4%, p<0.0001).

C. Kaplan-Meier analysis of two year survival for patients with locoregional pancreatic adenocarcinoma and EUS, in patients who did not undergo surgery. EUS group had improved survival (8.6% vs. 5.6%, p<0.0001)